ANGPTL8 (Betatrophin) is Expressed in Visceral Adipose Tissue and Relates to Human Hepatic Steatosis in Two Independent Clinical Collectives
- 28 March 2017
- journal article
- research article
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 49 (05) , 343-349
Abstract
Angiopoietin-like protein 8 (ANGPTL8)/betatrophin expression in visceral adipose tissue and associations with circulating fatty acid profile have not yet been investigated. Forty subjects were included in a cross-sectional study, 57 in a dietary weight reduction intervention. Circulating Angiopoietin-like protein 8/betatrophin was measured in all subjects. Liver and adipose tissue were sampled and plasma fatty acids and tissue Angiopoietin-like protein 8/betatrophin expression were evaluated in the cross-sectional study. In the intervention study oral glucose testing and liver magnetic resonance scanning at baseline and after 6 months were performed. Angiopoietin-like protein 8/betatrophin mRNA was increased in visceral compared to subcutaneous adipose tissue (p* Equal contributionKeywords
This publication has 32 references indexed in Scilit:
- Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistanceScientific Reports, 2015
- In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in ratsDiabetologia, 2015
- Circulating betatrophin is elevated in patients with type 1 and type 2 diabetesEndocrine Journal, 2015
- ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell ExpansionCell, 2014
- Circulating Betatrophin Concentrations Are Decreased in Human Obesity and Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2014
- Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic PatientsDiabetes Care, 2014
- Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesityScientific Reports, 2014
- Increased Circulating Betatrophin Concentrations in Patients with Type 2 DiabetesInternational Journal of Endocrinology, 2014
- Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individualsDiabetologia, 2014
- RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell ProliferationCell, 2013